Table: Delta-Fly Pharma -2022/23 parent results

Delta-Fly Pharma

15/05/2023 07:05

May 15 (Reuters)- 
          Delta-Fly Pharma, Inc. 
          PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                  Year ended       Year ended        Year to         NEXT   
               Mar 31, 2023     Mar 31, 2022     Mar 31, 2024      YEAR     
                  LATEST          YEAR-AGO         COMPANY        COMPANY   
                 RESULTS          RESULTS          FORECAST     H1 FORECAST 
  Sales                           300 mln                                   
               (-100.0 pct)      (+0.0 pct)                                 
  Operating     loss 1.32       loss 961 mln      loss 1.31                 
  Recurring     loss 1.33       loss 964 mln      loss 1.32                 
  Net           loss 1.33       loss 967 mln      loss 1.32                 
  EPS        loss 234.51 yen  loss 178.58 yen  loss 207.71 yen              
  Ann Div          NIL              NIL              NIL                    
  -Q2 Div          NIL              NIL              NIL                    
  -Q4 Div          NIL              NIL              NIL                    
  
  NOTE - Delta-Fly Pharma, Inc.. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4598.T